Home » KENYA REQUIRES MORE HIV/AIDS FUNDING
KENYA REQUIRES MORE HIV/AIDS FUNDING
May 22, 2006
Approximately $55 million is required annually to continue Kenya's comprehensive HIV/AIDS vaccine program, according to the locally based International Aids Vaccine Initiative (IAVI).
At present, said Samuel Kalibala, regional representative of the IAVI, approximately $30 million is spent each year on vaccine research and trials.
Kalibala said that 70 people had been involved in HIV/AIDS vaccine trials in Kenya since 2001, and noted that more than 50 percent of them had developed what he termed "good immunity" as a result of the treatment. He added, however, that "it will not be until the end of 2008 that the trials are completed and conclusive results are attained."
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct